Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Department of Surgery, Division of Breast Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Ann Surg Oncol. 2024 Oct;31(11):7609-7618. doi: 10.1245/s10434-024-15794-9. Epub 2024 Jul 31.
Consensus guidelines recommend ≥ 2 mm margins in patients undergoing partial mastectomy (PM) for ductal carcinoma in situ (DCIS). It is unknown whether the number or proximity of margins less than 2 mm is associated with an increased mastectomy rate in patients attempting breast conservation therapy (BCT) for DCIS. The aim of this study is to examine this relationship.
An institutional database review identified 208 patients with DCIS who underwent PM at a tertiary referral center and community hospitals from July 2020 to June 2023. Patients with a history of breast cancer, previous surgery for breast cancer, ipsilateral invasive carcinoma, papillary carcinoma, Paget's disease, more lobular carcinoma in situ (LCIS) than DCIS present, initial mastectomy, no DCIS present, routine shave margins (of all vectors), and ≥ 2 mm margins of all six vectors were excluded. Selective intraoperative margin re-excisions were included.
A total of 208 patients who met inclusion criteria were retrospectively reviewed. 122 (25%) had one close/positive (< 2 mm) margin and 86 (18%) had two or more close/positive margins. Of the patients with one close/positive margin, 7% (9/122) eventually underwent mastectomy. Of the patients with two or more close/positive margins, 20% (17/86) eventually underwent mastectomy. Overall, no patients with opposing margins underwent mastectomy.
Patients undergoing PM for DCIS have a mastectomy rate that is increased threefold, with two or more close/positive margins at initial PM, when compared with those with only one close/positive margin. The presence of opposing close/positive margins at initial PM did not increase the mastectomy rate and most were cleared with re-excision.
共识指南建议在接受导管原位癌(DCIS)部分乳房切除术(PM)的患者中,切缘应≥2 毫米。目前尚不清楚,当尝试保乳治疗(BCT)的 DCIS 患者的切缘小于 2 毫米的数量或接近程度是否与乳房切除术率增加有关。本研究旨在研究这种关系。
对一个三级转诊中心和社区医院 2020 年 7 月至 2023 年 6 月期间进行 PM 的 208 例 DCIS 患者的机构数据库进行了回顾性分析。排除了有乳腺癌病史、既往乳腺癌手术、同侧浸润性癌、乳头状癌、Paget 病、更多小叶原位癌(LCIS)比 DCIS 多、初始乳房切除术、无 DCIS、常规磨边(所有向量)和所有六个向量的切缘≥2 毫米的患者。包括选择性术中切缘再次切除。
共回顾了 208 例符合纳入标准的患者。122 例(25%)有 1 个接近/阳性(<2 毫米)切缘,86 例(18%)有 2 个或更多接近/阳性切缘。在有 1 个接近/阳性切缘的患者中,7%(9/122)最终行乳房切除术。在有 2 个或更多接近/阳性切缘的患者中,20%(17/86)最终行乳房切除术。总的来说,没有对侧接近/阳性切缘的患者行乳房切除术。
与仅有 1 个接近/阳性切缘的患者相比,PM 治疗 DCIS 的患者在初始 PM 有 2 个或更多接近/阳性切缘时,其乳房切除术率增加了 3 倍。初始 PM 有对侧接近/阳性切缘的存在并未增加乳房切除术率,且大多数通过再次切除得到清除。